Literature DB >> 21280177

17β-estradiol regulates estrogen receptor α monoubiquitination.

Piergiorgio La Rosa1, Maria Marino, Filippo Acconcia.   

Abstract

Monoubiquitination is a nonproteolytic signal involved in a network of several different physiological processes. Recently, monoubiquitination has been discovered as a new post-transductional modification of the estrogen receptor α (ERα). However, at present no information is available about the role of the cognate ligand 17β-estradiol (E2) in modulating this receptor post-transductional modification. Thus, we studied the E2-dependent modulation of ERα monoubiquitination in different cell lines. Here, we report that ERα monoubiquitination isnegatively modulated by E2. These results demonstrate thatERα monoubiquitination represents a new signalling modification that may modulate the E2:ERα-regulated cellular processes.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280177     DOI: 10.1002/iub.414

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  6 in total

1.  Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.

Authors:  Piergiorgio La Rosa; Valeria Pesiri; Guy Leclercq; Maria Marino; Filippo Acconcia
Journal:  Mol Endocrinol       Date:  2012-03-22

Review 2.  Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

Authors:  Kyle T Helzer; Christopher Hooper; Shigeki Miyamoto; Elaine T Alarid
Journal:  J Mol Endocrinol       Date:  2015-05-05       Impact factor: 5.098

3.  Clathrin Heavy Chain Interacts With Estrogen Receptor α and Modulates 17β-Estradiol Signaling.

Authors:  Pierangela Totta; Valeria Pesiri; Masato Enari; Maria Marino; Filippo Acconcia
Journal:  Mol Endocrinol       Date:  2015-04-10

Review 4.  The BRCA1/BARD1 ubiquitin ligase and its substrates.

Authors:  Samuel R Witus; Mikaela D Stewart; Rachel E Klevit
Journal:  Biochem J       Date:  2021-09-30       Impact factor: 3.857

Review 5.  Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer.

Authors:  Angeles C Tecalco-Cruz; Marina Macías-Silva; Josué Orlando Ramírez-Jarquín; Uri Nimrod Ramírez-Jarquín
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

6.  SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.

Authors:  Ting Zhuang; Sifan Yu; Lichen Zhang; Huijie Yang; Xin Li; Yingxiang Hou; Zhenhua Liu; Yuanyuan Shi; Weilong Wang; Na Yu; Anqi Li; Xuefeng Li; Xiumin Li; Gang Niu; Juntao Xu; Muhammad Sharif Hasni; Kun Mu; Hui Wang; Jian Zhu
Journal:  Oncotarget       Date:  2017-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.